Humulin 70/30 and Pregnancy

In most cases, Humulin 70/30 is considered safe to take during pregnancy. Since it is very important for pregnant women with diabetes to control their blood sugar, the benefits of the insulin medication may outweigh any potential risks. If you are using Humulin 70/30 and pregnancy occurs, notify your healthcare provider, as pregnancy may affect your insulin requirements.

Can I Take Humulin 70/30 During Pregnancy?

Humulin® 70/30 (NPH insulin/regular insulin) is a non-prescription diabetes medication that contains two different types of insulin. As with many types of insulin, Humulin 70/30 is generally considered to be safe for pregnant women. It has been around long enough for healthcare providers to have plenty of experience with the use of this medication during pregnancy.
 

Pregnancy Category B

The U.
 S. Food and Drug Administration (FDA) uses a pregnancy category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category B is given to medicines that have not been adequately studied in pregnant humans but do not appear to cause harm to the fetus in animal studies.
 
Although it was originally thought that insulin molecules are too large to cross the placenta, it is now known that some insulins, in some circumstances, may cross the placenta. In general, most healthcare providers consider Humulin 70/30 to be safe for use during pregnancy. It is very important for pregnant women with diabetes (including gestational diabetes) to control their blood sugar, and Humulin 70/30 can be useful to help keep blood sugar under control.
 
The most significant risk to a pregnant woman (or to anyone, for that matter) due to the use of insulin is dangerously low blood sugar. Be sure to check your blood sugar often, and be sure you know exactly what to do if you experience low blood sugar.
 
(Humulin 70/30 and Pregnancy Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation